CARPACCIO.cloud

Villeurbanne, France

CARPACCIO.cloud aims to revolutionize a particularly time-consuming, unattractive and unrewarding step of neuromuscular research: acquiring data on the number, size, type and the physiological state of the muscle fibers of the microscope images. This, thanks to an image analysis software, distributed as an online service. The fields of application cover a wide field of diseases such as genetic diseases, autoimmune diseases, metabolic diseases and cancers. A diversification is envisaged in other fields and tissues where a similar approach is used. CARPACCIO.cloud proposes new solutions for the acquisition of muscle cross-section parameters: contour / perimeter; Cytoplasmic labeling; Presence of "central" nuclei indicating muscle regeneration; As well as other control parameters such as circularity and minimum diameter of Ferret. This, more than 2000 times faster than by hand, with precision close to 97% - equivalent of the comparison between two manipulators. CARPACCIO.cloud automatically performs the analysis of all parameters of a muscle with 3000 fibers which would take someone over 2.5 days in less than one minute. All this via a web interface accessible from any terminal – desktop, laptop, tablet, smartphone - anywhere in the world!

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out CARPACCIO.cloud on @MedStartr Today #AutoimmuneDiseases #MetabolicDiseases #AutoimmuneDisorders #Cancer #MedMo #MedStartrVentures

https://www.medstartr.ai/s/_BWt7lA7ttU

Get Involved in CARPACCIO.cloud

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: www.carpaccio.cloud

Disease Areas

Autoimmune Disease Metabolic Diseases

Technologies

AutomationData AnalysisAI AlgorithmsComputational Biology

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of CARPACCIO.cloud?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.